Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raydiance was a leading developer of ultrafast femtosecond laser technology designed for high-precision manufacturing and medical applications. The company's proprietary platform enabled "cold" ablation, allowing for the machining of heat-sensitive materials used in life sciences, such as bioresorbable stents and catheters, without damaging the surrounding tissue or material structure. Beyond manufacturing, its technology was utilized in ophthalmic surgery for precise tissue cutting and refractive correction. Raydiance's solutions addressed the critical need for extreme precision in the production of next-generation medical implants. The company was acquired by Coherent in 2015 to strengthen its portfolio of industrial and medical laser systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raydiance.